Vivus Inc. | search
Click here to view Vivus Inc. news from 60+ newspapers.
Bookmark or Share- VIVUS Seeks Bankruptcy Court Approval of Second Amended - GlobeNewswireVIVUS is a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs.
- VIVUS: Advancing Innovative Clinical TherapiesWith demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases.
- Vivus - WikipediaVivus (OTC Pink: VVUSQ) is a small pharmaceutical company headquartered in Campbell, California, working in obesity, sleep, and sexual health. Vivus developed an erectile dysfunction drug, Avanafil, that has completed Phase 3 clinical trials. [1] The drug has been approved for use by the FDA, and is sold under the trademark name Stendra. [2]
- Vivus Inc Registered Shs - Markets InsiderVIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity, diabetes, sleep apnea and sexual health...
- Vivus to be owned by IEH Biopharma ahead of Chapter 11 filingIEH Biopharma LLC is taking 100% ownership of Vivus Inc. under an in-court prepackaged plan of reorganization ahead of the Vivus' Chapter 11 bankruptcy filing.
More
